• miR-709 inhibits GHRP6 induced GH synthesis by targeting PRKCA in pituitary
  Catalog No.:BS1577        Pubmed No.:32084499        PMCID:
  Details:
  Journal name:
• miR-709 inhibits GHRP6 induced GH synthesis by targeting PRKCA in pituitary
  Catalog No.:BS13278        Pubmed No.:32084499        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:BS4621        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:BS4621        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:AP0484/        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:AP0490        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:BS1236        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:BS1229        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:AP0231        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:BS4605        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway
  Catalog No.:AP0076        Pubmed No.:32877753        PMCID:
  Details:
  Journal name:
• Paternal systemic inflammation induces offspring programming of growth and liver regeneration in association with Igf2 upregulation
  Catalog No.:AP0060        Pubmed No.:32882328        PMCID:
  Details:
  Journal name:
• Protective Effects of 1-Methylnicotinamide on Aβ1–42-Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice
  Catalog No.:BS6007M        Pubmed No.:30635816        PMCID:
  Details:
  Journal name:
• Dentin-Derived Inorganic Minerals Promote the Osteogenesis of Bone Marrow-Derived Mesenchymal Stem Cells: Potential Applications for Bone Regeneration
  Catalog No.:AP006        Pubmed No.:33293964        PMCID:
  Details:
  Journal name:
• iRoot SP Promotes Osteo/Odontogenesis of Bone Marrow Mesenchymal Stem Cells via Activation of NF-κB and MAPK Signaling Pathways
  Catalog No.:BS70836        Pubmed No.:33424977        PMCID:
  Details:
  Journal name: